臨床眼科73巻8号

2019年08月発行

連載 今月の話題

近視進行抑制—最近の動向

著者： 平岡孝浩¹

所属機関： ¹筑波大学医学医療系眼科

ページ範囲：P.979 - P.989

　近視進行抑制治療の確立は世界的にも最重要かつ急務の課題の1つであり，将来的なquality of vision（QOV），quality of life（QOL）を守るという観点のみならず，医療経済的な観点からも社会へ及ぼす影響はきわめて大きく，研究者が総力を挙げて取り組むべきテーマである。本稿では近年の近視研究に関して臨床研究を中心としてレビューし，その潮流について解説する。

参考文献

1）Dolgin E：The myopia boom. Nature 519（7543）：276-278, 2015

2）Vitale S, Sperduto RD, Ferris FL 3rd：Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol 127：1632-1639, 2009

3）Holden BA, Fricke TR, Wilson DA et al：Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology 123：1036-1042, 2016

4）Flitcroft DI：The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res 31：622-660, 2012

5）Yamada M, Hiratsuka Y, Roberts CB et al：Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol 17：50-57, 2010

6）Iwase A, Araie M, Tomidokoro A et al：Prevalence and causes of low vision and blindness in a Japanese adult population：the Tajimi Study. Ophthalmology 113：1354-1362, 2006

7）Solouki AM, Verhoeven VJ, van Duijn CM et al：A genome-wide association study identifies a susceptibility locus for refractive errors and myopia at 15q14. Nat Genet 42：897-901, 2010

8）Hysi PG, Young TL, Mackey DA et al：A genome-wide association study for myopia and refractive error identifies a susceptibility locus at 15q25. Nat Genet 42：902-905, 2010

9）Kiefer AK, Tung JY, Do CB et al：Genome-wide analysis points to roles for extracellular matrix remodeling, the visual cycle, and neuronal development in myopia. PLoS Genet 9：e1003299, 2013

10）Verhoeven VJ, Hysi PG, Wojciechowski R et al：Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet 45：314-318, 2013

11）Fan Q, Verhoeven VJ, Wojciechowski R et al：Meta-analysis of gene-environment-wide association scans accounting for education level identifies additional loci for refractive error. Nat Commun 7：11008, 2016

12）Jones LA, Sinnott LT, Mutti DO et al：Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci 48：3524-3532, 2007

13）Sherwin JC, Reacher MH, Keogh RH et al：The association between time spent outdoors and myopia in children and adolescents：a systematic review and meta-analysis. Ophthalmology 119：2141-2151, 2012

14）Xiong S, Sankaridurg P, Naduvilath T et al：Time spent in outdoor activities in relation to myopia prevention and control：a meta-analysis and systematic review. Acta Ophthalmol 95：551-566, 2017

15）Yazar S, Hewitt AW, Black LJ et al：Myopia is associated with lower vitamin D status in young adults. Invest Ophthalmol Vis Sci 55：4552-4559, 2014

16）Choi JA, Han K, Park YM et al：Low serum 25-hydroxyvitamin D is associated with myopia in korean adolescents. Invest Ophthalmol Vis Sci 55：2041-2047, 2014

17）Cohen Y, Belkin M, Yehezkel O et al：Dependency between light intensity and refractive development under light-dark cycles. Exp Eye Res 92：40-46, 2011

18）Karouta C, Ashby RS：Correlation between light levels and the development of deprivation myopia. Invest Ophthalmol Vis Sci 56：299-309, 2015

19）Torii H, Ohnuma K, Kurihara T et al：Violet light transmission is related to myopia progression in adult high myopia. Sci Rep 7：14523. doi:10.1038/s41598-017-09388-7, 2017

20）Torii H, Kurihara T, Seko Y et al：Violet light exposure can be a preventive strategy against myopia progression. Ebiomedicine 15：210-219, 2017

21）Chua WH, Balakrishnan V, Chan YH et al：Atropine for the treatment of childhood myopia. Ophthalmology 113：2285-2291, 2006

22）Chia A, Chua WH, Cheung YB et al：Atropine for the treatment of childhood myopia：safety and efficacy of 0.5％, 0.1％, and 0.01％ doses（Atropine for the Treatment of Myopia 2）. Ophthalmology 119：347-354, 2012

23）Chia A, Lu QS, Tan D：Five-Year clinical trial on atropine for the treatment of myopia 2：myopia control with atropine 0.01％ eyedrops. Ophthalmology 123：391-399, 2016

24）Schwahn HN, Kaymak H, Schaeffel F：Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick. Vis Neurosci 17：165-176, 2000

25）Gwiazda J, Thorn F, Bauer J et al：Myopic children show insufficient accommodative response to blur. Invest Ophthalmol Vis Sci 34：690-694, 1993

26）Gwiazda J, Hyman L, Hussein M et al：A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci 44：1492-1500, 2003

27）Gwiazda JE, Hyman L, Norton TT et al：Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children. Invest Ophthalmol Vis Sci 45：2143-2151, 2004

28）Hasebe S, Ohtsuki H, Nonaka T et al：Effect of progressive addition lenses on myopia progression in Japanese children：a prospective, randomized, double-masked, crossover trial. Invest Ophthalmol Vis Sci 49：2781-2789, 2008

29）長谷部　聡：眼鏡による近視進行防止．再考！近視メカニズム—実臨床のために—OCULISTA 4：60-66，2013

30）Smith EL 3rd, Kee CS, Ramamirtham R et al：Peripheral vision can influence eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci 46：3965-72, 2005

31）Kanda H, Oshika T, Hiraoka T et al：Effect of spectacle lenses designed to reduce relative peripheral hyperopia on myopia progression in Japanese children：a 2-year multicenter randomized controlled trial. Jpn J Ophthalmol 62：537-543, 2018

32）Kakita T, Hiraoka T, Oshika T：Influence of overnight orthokeratology on axial elongation in childhood myopia. Invest Ophthalmol Vis Sci 52：2170-2174, 2011

33）Hiraoka T, Kakita T, Okamoto F et al：Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia：a 5-year follow-up study. Invest Ophthalmol Vis Sci 53：3913-3919, 2012

34）Cho P, Cheung SW：Retardation of myopia in Orthokeratology（ROMIO）study：a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci 53：7077-7085, 2012

35）Li SM, Kang MT, Wu SS et al：Efficacy, safety and acceptability of orthokeratology on slowing axial elongation in myopic children by meta-analysis. Curr Eye Res 41：600-608, 2016

36）Sun Y, Xu F, Zhang T et al：Orthokeratology to control myopia progression：a meta-analysis. PLoS One 10：e0124535, 2015

37）Si JK, Tang K, Bi HS et al：Orthokeratology for myopia control：a meta-analysis. Optom Vis Sci 92：252-257, 2015

38）Wen D, Huang J, Chen H et al：Efficacy and acceptability of orthokeratology for slowing myopic progression in children：a systematic review and meta-analysis. J Ophthalmol 2015：360806, 2015

39）Hiraoka T, Sekine Y, Okamoto F et al：Safety and efficacy following 10-years of overnight orthokeratology for myopia control. Ophthalmic Physiol Opt 38：281-289, 2018

40）Sankaridurg P, Holden B, Smith E 3rd et al：Decrease in rate of myopia progression with a contact lens designed to reduce relative peripheral hyperopia：one-year results. Invest Ophthalmol Vis Sci 52：9362-9367, 2011

41）Anstice NS, Phillips JR：Effect of dual-focus soft contact lens wear on axial myopia progression in children. Ophthalmology 118：1152-1161, 2011

42）Fujikado T, Ninomiya S, Kobayashi T et al：Effect of low-addition soft contact lenses with decentered optical design on myopia progression in children：a pilot study. Clin Ophthalmol 8：1947-1956, 2014

43）Chamberlain P, Back A, Lazon P et al：3 year effectiveness of a dual-focus 1 day soft contact lens for myopia control. Presented at the 40th British Contact Lens Association Clinical Conference and Exhibition；10 June 2017；Liverpool, United Kingdom

44）Cooper J, O'Connor B, Watanabe R et al：Case series analysis of myopic progression control with a unique extended depth of focus multifocal contact lens. Eye Contact Lens 44：e16-e24, 2018

45）Kinoshita N, Konno Y, Hamada N et al：Additive effects of orthokeratology and atropine 0.01％ ophthalmic solution in slowing axial elongation in children with myopia：first year results. Jpn J Ophthalmol 62：544-553, 2018